Rudin Glaucoma Prize winner announced

Article

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

The professor of ophthalmology at Duke Eye Centre, Duke University School of Medicine, Durham, North Carolina, USA, was selected by the New York Academy of Medicine to receive the prize this year. He was presented with the award for his insightful research on fostering a greater understanding of glaucoma.

Dr David Abramson, Chair of the Lewis Rudin Prize Selection Committee and Chief of Ophthalmic Oncology at Memorial Sloan-Kettering Cancer Centre, said, "Dr Stamer's discovery of a previously unrecognized signalling molecule that is important in normal and glaucoma eyes (nitrous oxide synthase) opens entirely new areas for research and treatment of the most common glaucomas worldwide."

Additionally, Dr Stamer is Editor-in-Chief of the Journal of Ocular Pharmacology & Therapeutics and is a member of the editorial boards for Investigative Ophthalmology and Visual Science and Experimental Eye Research.

For more information on the Lewis Rudin Glaucoma Prize please visit the official webpage.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.